Related Experiment Video
Updated: Mar 12, 2026
07:12
Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
8.4K
The central cannabinoid receptor type-2 (CB2) and chronic pain
1a Department of Anesthesiology, West China Second Hospital , Sichuan University , Chengdu , China.
The International Journal of Neuroscience
|November 16, 2016
Summary
The Cannabinoid receptor type-2 (CB2) mediates pain relief through immune tissues and the central nervous system. Targeting CB2 receptors shows promise for treating chronic pain with potentially fewer side effects.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Cannabinoid receptor type-2 (CB2) plays a role in pain modulation.
- CB2 receptors are found in both peripheral immune tissues and the central nervous system (CNS).
- Understanding CB2 receptor mechanisms is crucial for pain management.
Purpose of the Study:
- To explore the dual mechanisms of CB2 receptor-mediated analgesia.
- To investigate the potential of CB2 as a therapeutic target for chronic pain.
Main Methods:
- Analysis of CB2 receptor expression in neural and immune cells.
- Evaluation of analgesic effects via cytokine modulation and neuronal pathways.
Main Results:
- CB2 receptors in peripheral immune tissues reduce pain by altering cytokine profiles.
- CB2 receptors expressed in CNS neurons and glial cells also contribute to pain attenuation.
- CB2-mediated analgesia appears to have limited adverse effects on the CNS.
Conclusions:
- CB2 receptor activation offers a potential therapeutic strategy for chronic pain.
- The distinct mechanisms of CB2 in peripheral and central systems warrant further investigation.
- CB2 receptor modulation presents a promising avenue for novel pain treatments.
Related Concept Videos
01:25Analgesia and Pain Management
2.6K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.6K
01:20Pain
1.7K
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
1.7K
01:22Opioid Receptors: Overview
5.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.8K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
884
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
884
01:44Nociception
33.7K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
33.7K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K